Literature DB >> 9451516

The use of intravenous nitroglycerin for cervico-uterine relaxation: a review of the literature.

P Dufour1, D Vinatier, F Puech.   

Abstract

The safety, predictability, and ease of intravenous administration of nitroglycerin (NTG) have been firmly documented. In recent years, intravenous NTG has come to the attention of the obstetrician as a potent uterine relaxant. Intravenous nitroglycerin has been used to relax the uterus during manual extraction of retained placenta and to permit replacement of a contracted, completely prolapsed, inverted uterus. The use of this agent as a tocolytic has previously been reported in cesarean delivery of twins, in cases of intra partum external cephalic version, and for internal intrapartum podalic version of the second twin. This new procedure was also used for fetal head entrapment after vaginal breech delivery. The authors report a review of the literature about this subject.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9451516     DOI: 10.1007/s004040050189

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  8 in total

1.  A novel treatment for management of a trapped placenta using intracervical nitroglycerin tablets.

Authors:  Blake Conley Rodgers; Adam Pasternak; Richard Gray
Journal:  BMJ Case Rep       Date:  2013-09-06

2.  Glyceryl trinitrate to reduce the need for manual removal of retained placenta following vaginal delivery: the GOT-IT RCT.

Authors:  Fiona C Denison; Kathryn F Carruthers; Jemma Hudson; Gladys McPherson; Graham Scotland; Sheonagh Brook-Smith; Cynthia Clarkson; Mathilde Peace; Jane Brewin; Gin Nie Chua; Nina Hallowell; Jane E Norman; Julia Lawton; John Norrie
Journal:  Health Technol Assess       Date:  2019-12       Impact factor: 4.014

3.  Nitric oxide donor-induced inhibition of pregnant rat uterine spontaneous contractile activity and release of nitric oxide from uterus measured by microdialysis.

Authors:  T Okawa; K Asano; H Takahashi; A Sato; Y P Vedernikov; G R Saade; R E Gafield
Journal:  J Endocrinol Invest       Date:  2005-12       Impact factor: 4.256

4.  Uterine Inversion; A case report.

Authors:  C Bouchikhi; H Saadi; B Fakhir; H Chaara; H Bouguern; A Banani; Ma Melhouf
Journal:  Libyan J Med       Date:  2008-03-01       Impact factor: 1.657

5.  Hysterotomy for retained placenta in a septate uterus: a case report.

Authors:  Daniel Lee; Joseph Johnson
Journal:  Case Rep Obstet Gynecol       Date:  2012-06-07

6.  Maternal and infant morbidity following birth before 27 weeks of gestation: a single centre study.

Authors:  Andrei S Morgan; Saadia Waheed; Shivani Gajree; Neil Marlow; Anna L David
Journal:  Sci Rep       Date:  2021-01-11       Impact factor: 4.379

Review 7.  Nitroglycerin for management of retained placenta.

Authors:  Hany Abdel-Aleem; Mahmoud A Abdel-Aleem; Omar M Shaaban
Journal:  Cochrane Database Syst Rev       Date:  2015-11-12

8.  Nitroglycerin for treatment of retained placenta: A randomised, placebo-controlled, multicentre, double-blind trial in the UK.

Authors:  Fiona C Denison; Kathryn F Carruthers; Jemma Hudson; Gladys McPherson; Gin Nie Chua; Mathilde Peace; Jane Brewin; Nina Hallowell; Graham Scotland; Julia Lawton; John Norrie; Jane E Norman
Journal:  PLoS Med       Date:  2019-12-30       Impact factor: 11.069

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.